55 related articles for article (PubMed ID: 2389407)
1. Serum type III procollagen as a marker in liver transplantation.
Höckerstedt K; Risteli L; Salmela K; Risteli J
Transplant Proc; 1990 Aug; 22(4):1574-5. PubMed ID: 2389407
[No Abstract] [Full Text] [Related]
2. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
Pagani A; Pranzo A; Sala N; Galante T
Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
[TBL] [Abstract][Full Text] [Related]
3. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
4. Type III procollagen peptide: studies on the circulating peptide as a marker of fibrinogenesis with special reference to the liver.
Bentsen KD
Dan Med Bull; 1993 Apr; 40(2):235-46. PubMed ID: 8495599
[No Abstract] [Full Text] [Related]
5. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
[TBL] [Abstract][Full Text] [Related]
6. [Serum determination of N-terminal peptide of type III procollagen as a marker of fibrotic activity].
García Montes JM; De Bonilla Blánez F; Herrerías Gutiérrez JM
Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):241-5. PubMed ID: 2734469
[TBL] [Abstract][Full Text] [Related]
7. Bone loss and turnover in patients with liver transplantation.
Hawkins FG; Leon M; Lopez MB; Valero MA; Larrodera L; Garcia-Garcia I; Loinaz C; Moreno Gonzalez E
Hepatogastroenterology; 1994 Apr; 41(2):158-61. PubMed ID: 8056405
[TBL] [Abstract][Full Text] [Related]
8. Auxiliary partial liver transplantation for acute and chronic liver disease.
Terpstra OT; Metselaar HJ; Hesselink EJ; de Rave S; Groenland TH; Stibbe J; Bakker CM; ten Kate FJ; Reuvers CB; Terpstra JL
Transplant Proc; 1990 Aug; 22(4):1564. PubMed ID: 2389402
[No Abstract] [Full Text] [Related]
9. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
10. [Follow-up of liver transplantation].
Vasseur B; Samuel D
Gastroenterol Clin Biol; 1999 Jun; 23(5 Pt 2):B66-75. PubMed ID: 10897776
[No Abstract] [Full Text] [Related]
11. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
Zachariae H; Søgaard H; Heickendorff L
Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
13. Hepatic retransplantation: the Hannover experience of two decades.
Fangmann J; Ringe B; Hauss J; Pichlmayr R
Transplant Proc; 1993 Feb; 25(1 Pt 2):1077-8. PubMed ID: 8442048
[No Abstract] [Full Text] [Related]
14. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
15. Aminoterminal propeptide of type III procollagen reflects formation of collagen following rejection after heart transplantation.
Høst NB; Aldershvile J; Jensen LT; Mortensen SA; Pettersson G; Høyer S; Haunsø S
Transplant Proc; 1994 Jun; 26(3):1813. PubMed ID: 8030150
[No Abstract] [Full Text] [Related]
16. Detection of lipid peroxidation products by malondialdehyde (MDA-TBA reaction) in organ transplantation.
Auer T; Khoschsorur GA; Rabl H; Iberer F; Petutschnigg B; Wasler A; Tscheliessnigg KH
Transplant Proc; 1995 Oct; 27(5):2749-51. PubMed ID: 7482900
[No Abstract] [Full Text] [Related]
17. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
18. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value.
Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B
Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality of children with chronic liver diseases who were listed for liver transplantation in Iran.
Dehghani SM; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Imanieh MH; Haghighat M; Davari HR; Mehrabani D; Malek-Hosseini SA
Pediatr Transplant; 2007 Feb; 11(1):21-3. PubMed ID: 17239119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
